A new survey reveals that support from healthcare providers and self-administered cervical cancer screening options can alleviate testing anxiety and encourage participation.
BERLIN, Jan. 29, 2025 — During Cervical Cancer Awareness Month, Clue, a leading period and reproductive health tracking app, released a survey identifying key obstacles women and people with cycles face regarding cervical screenings. Analyzing data from over 7,800 global members, Clue found that while initial screenings cause anxiety for many, subsequent screenings become progressively more comfortable. The survey also indicated significant openness to self-testing options as a more accessible and comfortable alternative to traditional provider-administered tests.
Cervical cancer remains the fourth most prevalent cancer globally, especially in developing nations. In the U.S., over half of cervical cancer cases occur in individuals who have never undergone screening. Regular screenings are vital for early detection and prevention, improving outcomes and saving lives worldwide. However, fear and anxiety, particularly among younger demographics, often lead to delayed screenings.
Obstacles to Screening
Despite 90% of respondents recognizing the importance of cervical screenings, substantial barriers remain. For respondents over 26 who hadn’t been screened, the top reasons were:
- 32% believed screening wasn’t necessary
- 31% feared the procedure
- 22% felt embarrassed
- 20% didn’t know where to access screening
Among those screened, one in four felt unprepared and uninformed before their first test. Most respondents (30%) had their first screening at ages 19-21, with 84% completing a screening by age 26.
Improved Experiences After Initial Screening
Clue’s survey showed reduced pain reported during recent screenings compared to initial screenings, where anxiety is often highest.
Eight in ten described their first screening as neutral or positive, rising to nine in ten for their most recent screening.
- 32% reported no pain during their most recent screening—double the percentage who experienced no pain during their first screening.
Clue’s experts advise those experiencing pain or concerns to communicate with their healthcare provider. Providers can adjust techniques or offer comfort measures, such as breaks or lubrication.
Potential of Self-Administered Tests
The survey highlighted growing interest in self-administered HPV testing, with over half (51%) expressing interest. Only 18% opposed self-testing. Self-collection allows for sample collection during a healthcare visit or at home, avoiding traditional speculum-based examinations. The swab is less intrusive than tampons or speculums, reducing anxiety. Studies confirm self-collection’s reliability and lack of specialized training requirements.
Healthcare Providers’ Ongoing Crucial Role
Healthcare providers remain the primary source of screening information (69%), followed by internet searches (51%) and social media (29%). This highlights the critical role of medical professionals in patient education and comfort.
More information about the survey and additional data can be found on
About Clue
Clue is a leading women-led menstrual and reproductive health app with over 10 million users globally. Its science-focused approach enables users to build comprehensive health records, leveraging cycle data for insights into overall health. Covering cycle health education, fertility, pregnancy, menopause, and related aspects, the Clue app is CE-marked as a Class 1 medical-grade device. Clue collaborates with researchers from leading institutions to address data gaps in female health. Based in Berlin, Germany, Clue’s data is protected by stringent EU GDPR regulations and Clue’s commitment to user privacy.
CONTACT: press@helloclue.com